An Omics View of Emery–Dreifuss Muscular Dystrophy

An Omics View of Emery–Dreifuss Muscular Dystrophy

Recent progress in Omics technologies has started to empower personalized healthcare development at a thorough biomolecular level. Omics have subsidized medical breakthroughs that have started to enter clinical proceedings. The use of this scientific know-how has surfaced as a way to provide a more...

Full description

Bibliographic Details
Main Authors: Nicolas Vignier, Antoine Muchir
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Journal of Personalized Medicine
Subjects:
<i>LMNA</i>
Emery–Dreifuss muscular dystrophy
Omics
Online Access:https://www.mdpi.com/2075-4426/10/2/50
id doaj-8b35b3cdafeb46b295f5ca96b585af78
record_format Article
spelling doaj-8b35b3cdafeb46b295f5ca96b585af782020-11-25T03:06:16ZengMDPI AGJournal of Personalized Medicine2075-44262020-06-0110505010.3390/jpm10020050An Omics View of Emery–Dreifuss Muscular DystrophyNicolas Vignier0Antoine Muchir1INSERM, Center of Research in Myology, Institute of Myology, Sorbonne University, 75013 Paris, FranceINSERM, Center of Research in Myology, Institute of Myology, Sorbonne University, 75013 Paris, FranceRecent progress in Omics technologies has started to empower personalized healthcare development at a thorough biomolecular level. Omics have subsidized medical breakthroughs that have started to enter clinical proceedings. The use of this scientific know-how has surfaced as a way to provide a more far-reaching view of the biological mechanisms behind diseases. This review will focus on the discoveries made using Omics and the utility of these approaches for Emery–Dreifuss muscular dystrophy.https://www.mdpi.com/2075-4426/10/2/50<i>LMNA</i>Emery–Dreifuss muscular dystrophyOmics
collection DOAJ
language English
format Article
sources DOAJ
author Nicolas Vignier
Antoine Muchir
spellingShingle Nicolas Vignier
Antoine Muchir
An Omics View of Emery–Dreifuss Muscular Dystrophy
Journal of Personalized Medicine
<i>LMNA</i>
Emery–Dreifuss muscular dystrophy
Omics
author_facet Nicolas Vignier
Antoine Muchir
author_sort Nicolas Vignier
title An Omics View of Emery–Dreifuss Muscular Dystrophy
title_short An Omics View of Emery–Dreifuss Muscular Dystrophy
title_full An Omics View of Emery–Dreifuss Muscular Dystrophy
title_fullStr An Omics View of Emery–Dreifuss Muscular Dystrophy
title_full_unstemmed An Omics View of Emery–Dreifuss Muscular Dystrophy
title_sort omics view of emery–dreifuss muscular dystrophy
publisher MDPI AG
series Journal of Personalized Medicine
issn 2075-4426
publishDate 2020-06-01
description Recent progress in Omics technologies has started to empower personalized healthcare development at a thorough biomolecular level. Omics have subsidized medical breakthroughs that have started to enter clinical proceedings. The use of this scientific know-how has surfaced as a way to provide a more far-reaching view of the biological mechanisms behind diseases. This review will focus on the discoveries made using Omics and the utility of these approaches for Emery–Dreifuss muscular dystrophy.
topic <i>LMNA</i>
Emery–Dreifuss muscular dystrophy
Omics
url https://www.mdpi.com/2075-4426/10/2/50
work_keys_str_mv AT nicolasvignier anomicsviewofemerydreifussmusculardystrophy
AT antoinemuchir anomicsviewofemerydreifussmusculardystrophy
AT nicolasvignier omicsviewofemerydreifussmusculardystrophy
AT antoinemuchir omicsviewofemerydreifussmusculardystrophy
_version_ 1724674338245836800

Similar Items